“Attention $KRTL shareholders: Management has a press release scheduled for tomorrow, with more to follow in the coming days. Stay tuned—growth is on the horizon!”

Attention $KRTL Shareholders: Management is pleased to announce that multiple press releases are currently in preparation. We continue to make solid progress toward our strategic goals, including the evaluation and execution of merger and stacking opportunities. These moves are

Attention $KRTL Shareholders: We are pleased to announce that our year-end earnings report and 2024 Annual Report will be released this coming Monday. We look forward to sharing our progress and outlining the strategic direction for the year ahead.

Attention $KRTL Shareholders: Management would like to extend our sincere thanks for your continued loyalty. We are working diligently to deliver long-term value as we continue building out our Quality Management System (QMS) infrastructure. In parallel, we are actively pursuing

$KRTL KRTL Holding Group, Inc Commences Trading on Upstream Under KRTL Investors outside the U.S. can now deposit or trade KRTL securities by downloading Upstream from their preferred app store at upstream.exchange

“Big congratulations to all $KRTL shareholders! Exciting developments ahead — official press release dropping in the coming days. Stay tuned.”

“Big congrats once again to $KRTL shareholders! More press releases on the way — stay tuned!”

Attention $KRTL shareholders: KRTL Holding Group is proud to announce the successful acquisition of Neurogen. This strategic move marks a major milestone in expanding and integrating innovative ventures into our growing portfolio. Official press release coming soon.

$KRTL acquires: google.com/url?q=https://…

Attention $KRTL shareholders: A press release is scheduled for tomorrow — with more updates to follow. Stay tuned.

“Attention $KRTL shareholders: Sigma Pharmaceuticals has officially been approved to manufacture and distribute animal medications. Stay tuned!”

Attention $KRTL shareholders: We’ve officially started the process of trademarking “KRTL.” A law firm has been retained and paid. More updates soon as we solidify our brand for the future.

Attention $KRTL shareholders: Press release is coming this week, with more potentially on the way!

KRTL Holding Group Inc. Advances in 15c2-11 Process with Court-Approved Shareholder Verification Initiative globenewswire.com/NewsRoom/Relea…

Attention $kRTL Shareholders: A scheduled press release is set for tomorrow, followed by an additional release at a later date.

🚨 Attention $KRTL shareholders: PR is scheduled for tomorrow, with more to follow. Stay tuned. 📢

🚨 Attention $KRTL shareholders: Management is preparing press releases. One is scheduled for this week following a key third-party approval. Stay tuned. #KRTL #Biotech

$KRTL Profitability Update: Net income climbed 137% to $148,618 in Q2 2025 versus $62,790 in the prior year quarter, demonstrating the company's ability to convert increased revenue into bottom-line growth across their biotech and international divisions. #KRTL #NetIncome

📢 Attention $KRTL Shareholders: An updated press release expanding on our March 4, 2025 announcement is forthcoming. Stay tuned for important updates on our progress and next steps. #KRTL #ShareholderUpdate #PressRelease

📢 Attention $KRTL Shareholders: Following our March 24, 2025 announcement, an expanded press release is forthcoming. This update will encompass our progress to date and outline next steps. Stay tuned. #KRTL #Biotech #Shareholder